J. Am. Coll. Cardiol. 1992, 19, 792-802
313 SANDHOLZER C., SAHA N., DARK J., REES A., JAROSS W.,
et al
Apo(a) isoforms predict risk for coronary heart disease.
A study in six populations. Arterioscler. Thromb. 1992, 12,
1214-1226
314 FARRER
Coronary artery disease is associated with increased
lipoprotein(a) concentrations independent of the size of circulating
apolipoprotein(a) isoforms.
Arterioscler. Thromb. 1994, 14, 1272-1283
315 KINLAY S., DOBSON A., HELLER R., Mc ELDUFF P.,
ALEXANDER H., et al
Risk of primary and recurrent acute myocardial infarction
from lipoprotein(a) in men and women. J. Am. Coll. Cardiol. 1996, 28,
870-875
316 SUNAYAMA S., DAIDA H., MOKUNO H., MIYANO H., YOKOI
H., et al.
Lack of incresed coronary atherosclerosis risk due to
elevated lipoprotein(a) in women >_ 55 years of age.
Circulation 1996, 94, 1263-1268
317 SCHREINER P., MORROSETT J., SHARRET A.,
PATSCH W., TYROLER H., et al. Lipoprotein(a) as a risk factor for preclinical
atherosclerosis.
Arterioscler. Thromb. 1993, 13, 826-833
318 MOLITERNO D., LANGE R., MEIDELL R.,
WILLARD J., LEFFERT C. et al
Relation of plasma lipoprotein(a) to infarct artery
patency in survivors of myocardial infarction. Circulation 1993, 88,
935-940
319 ARMSTRONG V., NEUBAUER C., SCHULTZ E., TEBBE
U.
Lack of association between raised serum Lp(a)
concentration and unsuccessful thrombolysis after acute myocardial
infarction.
Lancet 1990, 336, 1077.
320 Von HODENBERG E., KREUZER J., HAUTMANN M., NORDT T.,
KUBLER W et al. Effects of lipoprotein(a) on success rate of thrombolytic
therapy in acute myocardial infarction. Am. J. Cardiol. 1991, 67,
1349-1353
Thèse Docteur Pharmacie La lipoprotéine Lp(a) :
son intérêt dans l'interprétation du bilan lipidique Dr
GUIMONT MC 264/271 Lipides, Lipoprotéine (a),
Hyperlipoprotéinémie, Athérosclérose, Lipids,
Lipoprotein, Lpa, Hyperlipoproteinemia, Atherosclerosis
321 MBEWU A.D., DURRINGTON P.N., MACKNESS M.I., HUNT L.,
TURKIE W.H. et al
Serum Lp(a) lipoprotein concentration and outcome of
thrombolytic treatment for myocardial infarction. Br. Heart J. 1994, 71,
316-321
322 HOFF H., BECK G., SKIBINSKI C., JURGENS G., O'NEIL
J., et al
Serum Lp(a) level as a predictor of vein graft stenosis
after coronary artery bypass surgery in patients. Circulation 1988, 77,
1238-1244
323 HEARN J., DONOHUE B., BAALBAKI H., DOUGLAS J., KING
S. et al
Usefulness of serum lipoprotein(a) as a predictor of
restenosis after percutaneous transluminal coronary angioplasty.
Am. J. Cardiol. 1992, 69, 736-739
324 SCHUMACHER M., TIRAN A., EBER B., TOPIAK H.,
WILDERS-TRUSCHNIG M., et al Lipoprotein(a) is not a risk factor for restenosis
after percutaneous transluminal coronary angioplasty. Am. J. Cardiol. 1992, 69,
572-?
323 BUSSIERE J.L., De BOURAYNE J., MONSEGU J., CORBE H.,
BERVILLE J.D. et al
Le taux plasmatique de lipoprotein(a) permet-il de
prédire la resténose après angioplastie? Arch. Mal. Coeur
Vaiss. 1996, 89, 425-429
326 KOSTNER G.
Standardization of Lp(a) assays. Clin. Chim. Acta 1992,
211, 191-194
327 ROSENGREN A., WILHELMSEN L., ERIKSSSON E., RISBERG
B., WEDEL H.
Lipoprotein(a) and coronary heart disease: a prospective
study in a general population sample of middle-aged men.
Br. Med. J. 1990, 301, 1248-1251
328 JAUHIAINEN M; KOSKINEN P., EHNHOLM C., FRICK H.,
MANTTARI M. et al
Lipoprotein(a) and coronary heart disease risk: a nested
case-control study of the Helsinki Heart Study participants.
Atherosclerosis 1991, 89, 56-67
328 SIGURDSSON G., BALDURSDOTTIRA., SIGVALDASON H.,
AGNARSSON U., THORGEIRSSON G., et al.
Predictive value of apolipoproteins in a prospective
survey of coronary artery disease in men. Am. J. Cardiol. 1992, 69,
1251-1254
338 RIDKER P., HENNEKENS C., STAMPFER M.
A prospective study of lipoprotein(a) and the risk of
myocardial infarction. JAMA 1993, 270, 2195-2199
331 SCHAEFER E., LAMON-FAVA S., JENNER J., McNAMARA J.,
ORDOVAS J., et al
Lipoprotein(a) levels and risk of coronary artery disease
in men. The Lipid Research Clinics Coronary Primary Prevention Trial. JAMA
1994, 271, 999-1003
332 CREMER P., NAGEL D., LABROT B., MANN H., MUCHE R., et
al.
Lipoprotein Lp(a) as predictor of myocardial infarction
in comparison to fibrinogen, LDL cholesterol and other factors: results from
the prospective Gottingen Risk Incidence and Prevalence Study
(GRIPS).
Eur. J. Clin. Invest. 1994, 24, 444-453
333 WALD N.J., LAW M., WATT H.C., WU T., BAILEY A., et
al.
Apolipoproteins and ischaemic heart disease: implications
for screening. Lancet 1994, 343, 75-79
Thèse Docteur Pharmacie La lipoprotéine Lp(a) :
son intérêt dans l'interprétation du bilan lipidique Dr
GUIMONT MC 265/271 Lipides, Lipoprotéine (a),
Hyperlipoprotéinémie, Athérosclérose, Lipids,
Lipoprotein, Lpa, Hyperlipoproteinemia, Atherosclerosis
334 TERRES W., TATSIS E., PFALZER B., BEIL U., BEISIEGEL
U., HAMM C.W.
Rapid angiographic progression of coronary artery disease
in patients with elevated lipoprotein(a). Circulation 1995, 91,
948-950
335 ASSMANN G., SCHULTE H., Von ECKARDSTEIN
A.
Hypertriglyceridemia and elevated lipoprotein(a) are risk
factors for major coronary events in middle-aged men.
Am. J. Cardiol. 1996, 77, 1179-1184
336 BOSTOM A.G., CUPPLES L.A., JENNER J.L., ORDOVAS J.M.,
SEMAN L.J., et al.
Elevated plasma lipoprotein(a) and coronary heart disease
in men aged 55 years and younger. Aprospective study.
JAMA 1996, 276, 544-548
337 WILD S.H., FORTMANN S.P., MARCOVINA S.M.
A prospective case-control study of lipoprotein(a) levels
and apo(a) size and risk of coronary heart disease in Standford Five-City
Project Participants. Arterioscl. Thromb. Vasc. Biol. 1997, 17,
239-245
338 ABE A., NOMA A.., LEE Y., YAMAGUCHI H.
Studies on apolipoprotein(a) phenotypes. Part 2.
Phenotypes frequencies and Lp(a) concentrations in different phenotypes in
patients with angiographically defined coronary artery diseases.
Atherosclerosis 1992, 96, 9-15
339 SEED M., HOPPICHLER F., REAVELEY D., Mc CARTHY S.,
THOMPSON G., et al.
Relation of serum lipoprotein(a) concentration and
apolipoprotein(a) phenotype to coronary heart disease in patients with familial
hypercholesterolemia.
N. Eng. J. Med. 1990, 322, 1494-1499
349 HOEFLER G., HARNONCOURT F., PASCHKE E., MIRTI W.,
PFEIFFER K., et al Lipoprotein Lp(a). A risk factor for myocardial
infaction.
Arterioscler. 1988, 8, 398-401
341 BAILLEUL S., COUDERC R., ROSSIGNOL C., FERMANIAN J.,
BOUTOUCHENT F., et al Lipoprotein(a) in childhood: relation with other
atheroslcerosis factors and family history of atherosclerosis.
Clin. Chem. 1995, 41, 241-245
342WILCKEN D., WANG X., DUDMAN N.
The relationship between infant and parent Lp(a)
levels.
Chem. Phys. Lipids 1994, 67/68, 299-304
343 MURAI A., MIYAHARA T., FUJIMOTO N., MATSUDA M.,
KAMEYAMA M. Lp(a) lipoprotein as a risk factor for coronary heart disease and
cerebral infarction. Atheroscl. 1986, 59, 199-204
344 ZENKER G., KOLTRINGER P., BONE G., NIEDERKORN K.,
PFEIFFER K., JURGENS G. Lipoprotein(a) as a strong indicator for
cerebrovascular infarction.
Stroke 1986, 17, 942-945
345 PEDRO-BOTET J., SENTI M., NOGUES X., RUBIES-PRAT J.,
ROQUET J.
Lipoprotein and apolipoprotein profile in men with
ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and
apolipoprotein E polymorphism.
Stoke 1992, 23, 1556-1562
346 JURGENS G., TADDEI-PETERS C., KOLTRINGER P., PETER
W., CHEN Q. et al
Lipoprotein(a) serum concentration and apolipoprotein(a)
phenotype correlate with severity and presence of ischemic cerebrovascular
disease.
Stroke 1995, 26, 1841-1848
Thèse Docteur Pharmacie La lipoprotéine Lp(a) :
son intérêt dans l'interprétation du bilan lipidique Dr
GUIMONT MC 266/271 Lipides, Lipoprotéine (a),
Hyperlipoprotéinémie, Athérosclérose, Lipids,
Lipoprotein, Lpa, Hyperlipoproteinemia, Atherosclerosis
347 WILLEIT J.W., KIECHL S., SANTER P., OBERHOLLENZER F.,
EGGER G. et al
Lipoprotein(a) and asymptomatic carotid artery disease.
Evidence of a prominent role in the evolution of advanced carotid plaques: the
Bruneck Study.
Stroke 1995, 26, 1582-1587
348 MARKUS H.S., KAPADIA R., SHERWOOD R.A.
Relatioship between lipoprotein(a) and both stroke and
carotid atheroma. Ann. Clin. Biochem. 1997, 34, 360-365
349 RIDKER P., STAMPFER M., HENNEKENS C.
Plasma concentration of lipoprotein(a) and the risk of
future stroke. JAMA 1995, 273, 1269-1273
359 NOGUES X., SENTI M., PEDRO-BOTET J., RUBIES-PRAT J.,
VIDAL-BARRAQUER F. Serum lipoprotein(a) levels in men with peripheral vascular
disease.
Angiology 1991, 42, 659-664
351 TYRREL J., COOKE T., REILLY M., COLGAN M., MOORE D.
et al Lipoprotein Lp(a) and peripheral vascular disease.
| 
